EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Emergence of biased hypermutation in a heterologous additional transcription unit in recombinant lentogenic Newcastle disease virus

Hendrik de Buhr, Olav S de Leeuw, Frank Harders, Ben P Peeters, Rik L de Swart

Journal of General Virology · 15.05.2023 · 104 (5)

DOI: 10.1099/jgv.0.001851 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of General Virology, erschienen am 15.05.2023. Verfasst von Hendrik de Buhr und 4 weiteren Autor:innen. Beteiligte Einrichtung: Wageningen Bioveterinary Research (WBVR), Lelystad, Netherlands. Hauptthemen laut MEDLINE: COVID-19, Viral Vaccines, Newcastle Disease. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recombinant Newcastle disease virus (rNDV) strains engineered to express foreign genes from an additional transcription unit (ATU) are considered as candidate live-attenuated vector vaccines for human and veterinary use. Early during the COVID-19 pandemic we and others generated COVID-19 vaccine candidates based on rNDV expressing a partial or complete SARS-CoV-2 spike (S) protein. In our studies, a number of the rNDV constructs did not show high S expression levels in cell culture or seroconversion in immunized hamsters. Sanger sequencing showed the presence of frequent A-to-G transitions characteristic of adenosine deaminase acting on RNA (ADAR). Subsequent whole genome rNDV sequencing revealed that this biased hypermutation was exclusively localized in the ATU expressing the spike gene, and was related to deamination of adenosines in the negative strand viral genome RNA. The biased hypermutation was found both after virus rescue in chicken cell line DF-1 followed by passaging in embryonated chicken eggs, and after direct virus rescue and subsequent passaging in Vero E6 cells. Levels of biased hypermutation were higher in constructs containing codon-optimized as compared to native S gene sequences, suggesting potential association with increased GC content. These data show that deep sequencing of candidate recombinant vector vaccine constructs in different phases of development is of crucial importance in the development of NDV-based vaccines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Viral VaccinesNewcastle DiseaseAnimalsHumansNewcastle disease virusCOVID-19 VaccinesPandemicsSARS-CoV-2ChickensVaccines, SyntheticRNA

Stichwörter der Autor:innen

ADAR1COVID-19NDV vaccineSARS-CoV-2spike protein

Substanzen

COVID-19 VaccinesVaccines, SyntheticRNAViral Vaccines

Autor:innen und Institutionen

  • Wageningen Bioveterinary Research (WBVR), Lelystad, Netherlands.

Zitieren

APA

de Buhr, H., de Leeuw, O. S., Harders, F., Peeters, B. P., & de Swart, R. L. (2023). Emergence of biased hypermutation in a heterologous additional transcription unit in recombinant lentogenic Newcastle disease virus. Journal of General Virology, 104(5). https://doi.org/10.1099/jgv.0.001851

Vancouver

de Buhr H, de Leeuw OS, Harders F, Peeters BP, de Swart RL. Emergence of biased hypermutation in a heterologous additional transcription unit in recombinant lentogenic Newcastle disease virus. Journal of General Virology. 2023;104(5). doi:10.1099/jgv.0.001851

BibTeX
@article{deBuhr2023,
  author = {de Buhr, Hendrik and de Leeuw, Olav S and Harders, Frank and Peeters, Ben P and de Swart, Rik L},
  title = {Emergence of biased hypermutation in a heterologous additional transcription unit in recombinant lentogenic Newcastle disease virus},
  journal = {Journal of General Virology},
  year = {2023},
  volume = {104},
  number = {5},
  doi = {10.1099/jgv.0.001851}
}
Kostenlos starten →